BVT Knock-Out ABT/ DE000VV93AN5 /
2024-11-12 8:44:16 PM | Chg.-0.04 | Bid9:17:40 PM | Ask9:17:40 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.19EUR | -3.25% | 1.21 Bid Size: 58,000 |
1.22 Ask Size: 58,000 |
Abbott Laboratories | 129.70 USD | 2078-12-31 | Put |
GlobeNewswire
08-06
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
06-06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
05-09
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
03-25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
03-15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
2023-11-14
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
2023-10-19
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer